Black Swan Research Initiative Team

Team Leaders


 
Brian G.M. Durie, MD
Chairman and Co-Founder
International Myeloma Foundation
North Hollywood, California
Prof. Jesús San Miguel, MD
Director of Clinical and Translational Medicine
University of Navarra
Pamplona, Spain
S. Vincent Rajkumar, MD
Professor of Medicine and Chair of the Mayo Clinic
Myeloma, Amyloidosis, and Dysproteinemia Group
Rochester, Minnesota

Iceland

 

Sigurdur Kristinsson, MD
University of Iceland
Reykjavík, Iceland

Stephen Harding, PhD
Research and Development Director
The Binding Site
Birmingham, United Kingdom

Kelly Endean
Head of Medical Science Liaison - Monoclonal Gammopathy
The Binding Site
Birmingham, United Kingdom

Sæmundur Rögnvaldsson
Researcher
University of Iceland
Reykjavík, Iceland

Ásdís Rósa Þórðardóttir
Project Manager
University of Iceland
Reykjavík, Iceland

Spain

 

Prof. Jesús San Miguel, MD
Director of Clinical and Translational Medicine
University of Navarra
Pamplona, Spain

Bruno Paiva, MD, PhD
University of Navarra
Pamplona, Spain

María-Victoria Mateos, MD, PhD
University of Salamanca
Salamanca, Spain

Alberto Orfao, MD, PhD
Department of Medicine, Cancer Research Center
University of Salamanca
Salamanca, Spain

Germany

Hartmut Goldschmidt, MD
Professor of Medicine (Hematology and Oncology) and Head of the Multiple Myeloma Program
University Hospital Heidelberg
Heidelberg, Germany

Jens Hillengass, MD*
University of Heidelberg
Heidelberg, Germany

*Now moved to Roswell Park Cancer Center, Buffalo, New York

Australia

Andrew Spencer, MD
Head of the Malignant Haematology & Stem Cell Transplantation Service
The Alfred Hospital
Professor
Monash University
Melbourne, Australia

France

Hervé Avet-Loiseau, MD
Head of the Laboratory for Genomics in Myeloma
University of Toulouse
Toulouse, France

Philippe Moreau, MD
University Hospital
Nantes, France

United States

Brian G.M. Durie, MD
Chairman and Co-Founder
International Myeloma Foundation
North Hollywood, California

Suzanne Lentzsch, MD, PhD
Associate Professor of Medicine and Director of the Multiple Myeloma and Amyloidosis Program
Columbia University and at New York Presbyterian Hospital
New York, New York

Saad Usmani, MD
Director of Clinical Research (Hematologic Malignancies), Director of Plasma Cell Disorders
Levine Cancer Institute, Carolinas Healthcare System
Charlotte, North Carolina

 

I2TEAMM for FDA Submission

Brian G.M. Durie, MD
Chairman and Co-Founder
International Myeloma Foundation
North Hollywood, California

Shaji Kumar, MD
Professor of Medicine, Hematology
Mayo Clinic
Rochester, Minnesota

Nikhil Munshi, MD
Professor of Medicine, Harvard Medical School
Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, Massachusetts

S. Vincent Rajkumar, MD
Professor of Medicine and Chair of the Mayo Clinic
Myeloma, Amyloidosis, and Dysproteinemia Group
Rochester, Minnesota

Prof. Jesús San Miguel, MD
Director of Clinical and Translational Medicine
University of Navarra
Pamplona, Spain

Qian Shi, PhD
Associate Professor of Biostatistics and Senior Associate Consultant
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research
Mayo Clinic Rochester, Rochester, MN

Philip McCarthy, MD
Professor of Oncology and Internal Medicine
Director, Blood and Marrow Transplant Center
Roswell Park Cancer Institute
Buffalo, New York

Paul Wallace, PhD
Professor of Oncology
Director, Department of Flow & Image Cytometry
Roswell Park Cancer Institute
Buffalo, New York

Theresa (Terri) Hahn, PhD
Professor of Oncology
Cancer Prevention and Population Sciences CCSG Program
Roswell Park Cancer Institute
Buffalo, New York

Joseph (Joe) Tario Jr., PhD
Senior Flow Cytometry Specialist
Department of Flow & Image Cytometry
Roswell Park Cancer Institute
Buffalo, New York

Marcelo Pasquini, MD
Associate Professor of Medicine
Scientific Director Center for International Blood and Marrow Transplant Research
Medical College of Wisconsin
Milwaukee, Wisconsin

Edward Stadtmauer, MD
Roseman, Tarte, Harrow, and Shaffer Families' President's Distinguished Professor
Section Chief, Hematologic Malignancies
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania

Hartmut Goldschmidt, MD
Professor of Medicine (Hematology and Oncology) and Head of the Multiple Myeloma Program
University Hospital Heidelberg
Heidelberg, Germany

Dirk Hose, MD
Head of the Multiple Myeloma Research Laboratory, Department of Internal Medicine
University of Heidelberg
Heidelberg, Germany

Stefanie Huhn, PhD
Department Head of the Multiple Myeloma Research Laboratory
University of Heidelberg
Heidelberg, Germany

Hervé Avet-Loiseau, MD
Head of the Laboratory for Genomics in Myeloma
University of Toulouse
Toulouse, France

Philippe Moreau, MD
University Hospital
Nantes, France

Michel Attal, MD
General Director
Institut Universitaire du Cancer de Toulouse-Oncopole
Toulouse, France

Andy Rawstron, PhD
Department of Hematology
St. James's University Hospital
Leeds, United Kingdom

Roger Owen, MD
Consultant Hematologist
St. James's University Hospital
Leeds, United Kingdom

Mario Boccadoro, MD
Professor
University of Torino
Torino, Italy

Stefania Oliva, MD
Myeloma Unit, Division of Hematology
University of Torino
Torino, Italy

Prof. Pieter Sonneveld, MD
Head of the Department of Hematology
Erasmus MC Cancer Institute, Rotterdam
The Netherlands

Shaji Kumar, MD
Professor of Medicine, Hematology
Mayo Clinic
Rochester, Minnesota

Kenneth (Ken) Anderson, MD
Kraft Family Professor of Medicine, Harvard Medical School
Physician, Oncology, Brigham And Women's Hospital
Dana-Farber Cancer Institute
Boston, Massachusetts

 

CESAR Trial

María-Victoria Mateos, MD, PhD
Director of the Myeloma Unit
University Hospital of Salamanca
Salamanca, Spain

Prof. Alberto Orfao, MD, PhD
Department of Medicine, Cancer Research Center
University of Salamanca
Salamanca, Spain

Bruno Paiva, MD, PhD
University of Navarra
Pamplona, Spain

Prof. Jesús San Miguel, MD
Director of Clinical and Translational Medicine
University of Navarra
Pamplona, Spain

Joan Bladé, MD
Hospital Clínica de Barcelona
Barcelona, Spain

Juan José Lahuerta, MD
Hospital Universitario 12 de Octubre
Madrid, Spain

 

ASCENT Trial

Brian G.M. Durie, MD
Chairman and Co-Founder
International Myeloma Foundation
North Hollywood, California

Shaji Kumar, MD
Professor of Medicine, Hematology
Mayo Clinic
Rochester, Minnesota

Global MRD Consortium

 

Wee-Joo Chng, MD, PhD Professor, Yong Loo Lin School of Medicine, National University of Singapore
Associate Director, Research, National University Cancer Institute, Singapore
Deputy Director, Cancer Science Institute of Singapore, National University of Singapore

Meletios Dimopoulos, MD
Professor and Chairman of the Department of Clinical Therapeutics
University Athens School of Medicine
Athens, Greece

Juan Du, MD
Changzhen Hospital
Shanghai, China

Roman Hajek, MD, PhD
Professor
University Hospital Brno and Masaryk University
Brno, Czech Republic

Heinz Ludwig, MD
Professor
Wilhelminenspital
Wien, Austria

Hareth Nahi, MD
Associate Professor
Karolinska University Hospital
Stockholm, Sweden

Evangelos Terpos, MD, PhD
Hematologist
University Athens School of Medicine
Athens, Greece

 

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt out, click for more information.